BackgroundCheck.run
Search For

Cynthia Lynn Parrish, 52Norristown, PA

Known as:
Cynthia L Parrish Cynthia L Breeden Cynthia L Lparrish Cynthia L Lbreeden Cindy J Parrish Cynthialynn Parrish John Parrish
Related to:
James Robert Parrish 52

Cynthia Parrish Phones & Addresses

King of Prussia, PA   

Arnold, MD   

7834 Shellye Rd, Glen Burnie, MD 21060    410-7877426   

Kng Of Prussa, PA   

Get Report
Control this profile

Mentions for Cynthia Lynn Parrish

Career records & work history

Lawyers & Attorneys

Cynthia Parrish Photo 1

Cynthia Parrish - Lawyer

ISLN:
909870315
Admitted:
1990
University:
Temple University, B.B.A., 1982
Law School:
Nova University, J.D., 1990

Cynthia Parrish resumes & CV records

Resumes

Cynthia Parrish Photo 40

Cynthia Parrish

Cynthia Parrish Photo 41

Cynthia Parrish

Cynthia Parrish Photo 42

Cynthia Parrish

Cynthia Parrish Photo 43

Cynthia Parrish

Cynthia Parrish Photo 44

Cynthia Parrish

Cynthia Parrish Photo 45

Cynthia Jo Boston Parrish

Cynthia Parrish Photo 46

Cynthia Parrish

Cynthia Parrish Photo 47

Cynthia Parrish

Publications & IP owners

Us Patents

N-(4-(Imidazo[1,2A]Pyridin-Yl)Phenethyl)Benzamide Inhibitors Of The Mitotic Kinesin Cenp-E For Treating Certain Cellular Proliferation Diseases

US Patent:
7504413, Mar 17, 2009
Filed:
Nov 9, 2005
Appl. No.:
11/271147
Inventors:
Xiangping Qian - Foster City CA, US
Gustave Bergnes - Pacifica CA, US
Dashyant Dhanak - West Chester PA, US
Steven D. Knight - West Chester PA, US
Nicholas D. Adams - Royersford PA, US
Cynthia A. Parrish - King of Prussia PA, US
Assignee:
Cytokinetics, Inc. - South San Francisco CA
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
C07D 471/02
A61K 31/4439
US Classification:
514300, 546121
Abstract:
Provided herein are certain substituted N-phenethylbenzamide of formula V:.

Quinoxaline Derivatives As Pi3 Kinase Inhibitors

US Patent:
7592342, Sep 22, 2009
Filed:
May 8, 2008
Appl. No.:
12/117127
Inventors:
Yanhong Feng - Collegeville PA, US
Cynthia A. Parrish - Collegeville PA, US
Martha A Sarpong - Collegeville PA, US
Domingos J Silva - Collegeville CA, US
Assignee:
SmithKline Beecham Corporation - Philadelphia PA
International Classification:
A61K 31/498
US Classification:
514249, 544353
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using quinoxaline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoxaline derivatives.

Compounds, Compositions And Methods

US Patent:
2007014, Jun 21, 2007
Filed:
Dec 17, 2004
Appl. No.:
10/583166
Inventors:
Cynthia Parrish - Collegeville PA, US
Dashyant Dhanak - Collegeville PA, US
International Classification:
A61K 31/36
C07D 311/78
C07D 317/44
A61K 31/277
A61K 31/16
US Classification:
514452000, 558406000, 564079000, 514522000, 514600000, 514464000, 549382000, 549440000
Abstract:
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.

Compounds, Compositions And Methods

US Patent:
2007025, Nov 8, 2007
Filed:
Dec 17, 2004
Appl. No.:
10/583403
Inventors:
Cynthia Parrish - Collegeville PA, US
Dashyant Dhanak - Collegeville PA, US
Steven Knight - Collegeville PA, US
David Morgans - Los Altos CA, US
Assignee:
SMITHKLINE BEECHAM CORPORATION - Philadelphia PA
CYTOKINETICS - San Francisco CA
International Classification:
A61K 31/18
A61K 31/36
A61K 31/396
A61P 35/00
C07C 311/00
C07D 229/02
C07D 317/46
US Classification:
514465000, 514183000, 514605000, 548960000, 549443000, 564099000
Abstract:
Compounds useful for treating cellular proliferative diseases and disorders by modulating the activity of KSP are disclosed.

Azaindole Inhibitors Of Aurora Kinases

US Patent:
2008008, Apr 3, 2008
Filed:
Sep 14, 2007
Appl. No.:
11/855183
Inventors:
Martha Sarpong - Collegeville PA, US
Nicholas Adams - Collegeville PA, US
Jeffrey Axten - Collegeville PA, US
Amita Chaudhari - Collegeville PA, US
Dashyant Dhanak - Collegeville PA, US
Toshihiro Hamajima - Tsukuba-shi, JP
Kenneth Newlander - Collegeville PA, US
Cynthia Parrish - Collegeville PA, US
Jerry Adams - Collegeville PA, US
Domingos Silva - Collegeville PA, US
Jun Tang - Durham NC, US
International Classification:
A61K 31/437
A61K 31/4545
A61K 31/496
A61K 31/506
A61K 31/5377
A61K 31/54
A61P 35/00
C07D 471/04
US Classification:
514228200, 514234500, 514252180, 514253040, 514300000, 544127000, 544295000, 544362000, 544058400, 546113000
Abstract:
The present invention relates to a compound represented by Formula (I): and pharmaceutically acceptable salts. Compounds of the present invention inhibit Aurora kinase, making them especially suitable for the treatment of a number of diseases, including solid tumor cancers and hematological cancers.

Naphthyridine, Derivatives As P13 Kinase Inhibitors

US Patent:
2010017, Jul 15, 2010
Filed:
May 29, 2008
Appl. No.:
12/602333
Inventors:
Nicholas D. Adams - Collegeville PA, US
Joelle L. Burgess - King of Prussia PA, US
Amita M. Chaudhari - Collegeville PA, US
David Knight - King of Prussia PA, US
Cynthia A. Parrish - King of Prussia PA, US
International Classification:
A61K 31/4375
C07D 471/04
A61K 31/496
A61K 31/5377
A61P 37/06
A61P 29/00
A61P 37/08
A61P 9/00
A61P 11/06
A61P 1/18
A61P 13/12
A61P 17/06
A61P 25/00
A61P 25/28
A61P 9/10
A61P 35/00
US Classification:
5142345, 546122, 514300, 544362, 51425304, 544127
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using naphthyridine derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of naphthyridine derivatives.

Pyridopyrimidine Derivatives As P13 Kinase Inhibitors

US Patent:
2010020, Aug 12, 2010
Filed:
Sep 17, 2008
Appl. No.:
12/678397
Inventors:
Kenneth Allen Newlander - Collegeville PA, US
Cynthia A. Parrish - Collegeville PA, US
International Classification:
A61K 31/519
C07D 471/04
C07D 413/14
A61K 31/5377
A61P 9/00
A61P 25/28
A61P 37/08
A61P 11/06
A61P 1/18
A61P 13/12
A61P 15/08
A61P 37/06
US Classification:
5142342, 544279, 544117, 5142641
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using pyridopyrimidine derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of pyridopyrimidine derivatives.

Quinoxaline Derivatives As Pi3 Kinase Inhibitors

US Patent:
2010023, Sep 16, 2010
Filed:
May 8, 2008
Appl. No.:
12/599544
Inventors:
Amita Chaudhari - Collegeville PA, US
Dashyant Dhanak - Collegeville PA, US
Carla Ann Donatelli - Collegeville PA, US
Thomas H. Faitg - Collegeville PA, US
Yanhong Feng - Collegeville PA, US
Steven David Knight - Collegeville PA, US
Cynthia A. Parrish - Collegeville PA, US
Jeffrey M. Ralph - Collegeville PA, US
Martha A. Sarpong - Collegeville PA, US
Domingos J. Silva - Collegeville PA, US
International Classification:
A61K 31/498
C07D 401/02
A61P 29/00
A61P 9/00
A61P 25/00
A61P 11/06
A61P 13/12
A61P 35/00
A61P 15/00
US Classification:
514249, 544353
Abstract:
Invented is a method of inhibiting the activity/function of PI3 kinases using quinoxaline derivatives. Also invented is a method of treating one or more disease states selected from: autoimmune disorders, inflammatory diseases, cardiovascular diseases, neurodegenerative diseases, allergy, asthma, pancreatitis, multiorgan failure, kidney diseases, platelet aggregation, cancer, sperm motility, transplantation rejection, graft rejection and lung injuries by the administration of quinoxaline derivatives.

Possible Relatives

David W Parrish  Dawn N Parrish  Dean Parrish  Deana M Parrish  Daimon C Parrish  Daisy Parrish  Dale W Parrish  Cynthia L Johnson  Cynthia A Stamps  Cynthia D Stanaway 

NOTICE: You may not use BackgroundCheck or the information it provides to make decisions about employment, credit, housing or any other purpose that would require Fair Credit Reporting Act (FCRA) compliance. BackgroundCheck is not a Consumer Reporting Agency (CRA) as defined by the FCRA and does not provide consumer reports.